Completed study

Official Study Title
An Open Label Phase II Trial to Evaluate the Safety of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa

Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites:  1 site in Greece
Actual enrolment: 12 participants Identifier: NCT03001622
EudraCT number: 2016-002988-33
National Organization for Medicines Approval: IS 90-16
National Ethics Committee Approval: 92/16

Study Start: December 2016
Study Completion: July 2017

Condition/Disease studied: Hidradenitis Suppurativa